FEB 26, 2021 1:41 AM PST

Good Bacteria Fights Bad Bacteria in a Clinical Trial

WRITTEN BY: Carmen Leitch

Eczema is a skin condition that causes a chronic, itchy rash. The most common form of the disorder, atopic dermatitis, is thought to affect around 18 million people in the United States. Researchers may have now found a surprising way to treat it. Reporting in Nature Medicine, they found that a strain of healthy bacteria that normally live on human skin can actually treat atopic dermatitis. The approach was just tested in Phase 1 clinical trial with human eczema patients. Out of 54 volunteers that received the treatment, two-thirds said their symptoms improved; they experienced less inflammation and itchiness. The therapeutic also did not have negative impacts.

Modified from a medical illustration of methicillin-resistant, Staphylococcus aureus (MRSA) bacteria / Credit: CDC/ Antibiotic Resistance Coordination and Strategy Unit / Photo Credit: Medical Illustrator: Meredith Newlove

"The main question we wanted to answer was if this was safe. This was a safety study," noted Richard Gallo, M.D., Ph.D., Ima Gigli Distinguished Professor of Dermatology and chair of the Department of Dermatology at the University of California San Diego School of Medicine. "We found exactly what we hoped to find. The eczema of participants who received the bacterial treatment improved and there were no adverse events."

Scientists have known that the human body, inside and out, plays host to many species of microbes. Not only are most of these microbes harmless, we need many of them to help us survive, such as by aiding in digestion or training the immune system. It's also known that we need 'good' bacteria' to prevent 'bad' bacteria from taking over these microbial communities.

Staphylococci are bacteria that often live on human skin without causing problems. But they can also cause infection. To find a strain of bacteria that could help eczema patients, the scientists analyzed over 8,000 isolates of healthy Staphylococcal bacteria to find the ones that could prevent the growth of a pathogenic strain of the bacterium called Staphylococcal aureus. S. aureus is known to worsen skin troubles like eczema.

After finding healthy Staphylococcal bacteria, the researchers took a closer look at the microbes, and found the ones that were least likely to damage skin or resist antibiotics. A strain called Staphylococcus hominis A9 emerged as a potential candidate for the treatment of atopic dermatitis.

"That's how we found the universal strain. This was one out of 8,000 strains that were tested in a dish for their ability to kill Staphylococcal aureus and treat atopic dermatitis," said Gallo. "And it worked."

This strategy was tested in a mouse model of eczema first, and it cured the mice after three days of twice-daily treatment. The Phase 1 trial was planned after that success.

"This research is a unique approach to targeting the harmful Staphylococcal aureus on atopic dermatitis skin with beneficial bacteria," said study co-author Donald Leung, M.D., allergist and immunologist at National Jewish Health. "It's our hope this will help patients with eczema rid their skin of the harmful bacteria causing the inflammation. Future studies will determine if this new cream can be used for long periods' of time to reduce the severity of eczema and improve the patient's quality of life."

"From our research, we've determined this rational therapeutic approach for atopic dermatitis appears to be safe for people to use to treat their eczema," said Gallo. "And it's easy, too, because it's just a cream and avoids the side effects of steroids and other drugs that target the immune system."

Sources: AAAS/Eurekalert! via University of California - San Diego, Nature Medicine

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JAN 18, 2021
Microbiology
Bacteria in Sediment is Likely Accelerating Greenland's Meltdown
JAN 18, 2021
Bacteria in Sediment is Likely Accelerating Greenland's Meltdown
For decades, scientists have been sounding the alarm about rising carbon dioxide levels in our planet's atmosphere, and ...
FEB 03, 2021
Microbiology
How Changing Shape Enables Bacteria to Avoid Antibiotics
FEB 03, 2021
How Changing Shape Enables Bacteria to Avoid Antibiotics
Bacteria are survivors, and they can find ways to get around stuff we use to kill them, like disinfectants and antibioti ...
FEB 17, 2021
Microbiology
A Microbial Cable That Uses Electricity to Live
FEB 17, 2021
A Microbial Cable That Uses Electricity to Live
There are species of bacteria that grow into centimeters-long colonies that have a cable shape and share a common coat. ...
MAR 02, 2021
Chemistry & Physics
Using materials science to fight SARS-CoV-2
MAR 02, 2021
Using materials science to fight SARS-CoV-2
Materials scientists around the world have been hard at work designing and developing materials with antiviral propertie ...
MAR 09, 2021
Immunology
A 'Plug-and-Play' CRISPR Therapy for Flu and COVID
MAR 09, 2021
A 'Plug-and-Play' CRISPR Therapy for Flu and COVID
Researchers have developed a CRISPR treatment that could potentially treat both viruses that cause COVID-19 and influenz ...
MAR 25, 2021
Immunology
The Immune System Impairs Antibiotic Effectiveness
MAR 25, 2021
The Immune System Impairs Antibiotic Effectiveness
Nitric oxide, a molecule produced by the immune system, can negatively impact antibiotics’ effectiveness, says a s ...
Loading Comments...